AAV2-hRPE65 vector

AAV2-RPE65 gene therapy vector · University of Pennsylvania

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AAV2-hRPE65 vector, covering 2025-08-05 to 2025-08-05. Get the full timeline:

Most recent: Clinical Trial Update: Phase I Trial of Gene Vector to Patients With Retinal Disease Due to RPE65 Mutations [Phase 1]